summary
Introduced
03/25/2025
03/25/2025
In Committee
03/25/2025
03/25/2025
Crossed Over
Passed
Dead
Introduced Session
119th Congress
Bill Summary
A BILL To amend title XVIII of the Social Security Act to provide for coverage and payment of Alpha-1 Antitrypsin Deficiency Disorder treatment under part B of such title, and for other purposes.
AI Summary
This bill, known as the "John W. Walsh Alpha-1 Home Infusion Act of 2025", aims to expand Medicare coverage for Alpha-1 Antitrypsin Deficiency Disorder (A1AD) treatment by adding a new provision to the Social Security Act. Specifically, the bill will allow Medicare Part B to cover augmentation therapy for A1AD patients, which is a treatment for adults with emphysema caused by a severe hereditary deficiency of Alpha-1 Antitrypsin. The treatment must be provided in the patient's home by qualified home infusion therapy suppliers and under the care of a physician, nurse practitioner, or physician assistant. Patients must be enrolled in both Medicare Part A and Part B and not in a Medicare Advantage plan. The bill establishes that Medicare will pay 80% of the cost for intravenous administration kits and up to two hours of nursing services associated with the treatment. These changes will take effect on January 1, 2027, and are designed to help patients with this rare genetic disorder receive necessary medical treatment in their homes with financial support from Medicare.
Committee Categories
Business and Industry
Sponsors (48)
María Salazar (R)*,
Don Bacon (R),
Janelle Bynum (D),
Troy Carter (D),
Herbert Conaway (D),
Angie Craig (D),
Sarah Elfreth (D),
Mike Flood (R),
Andrew Garbarino (R),
Laura Gillen (D),
Josh Gottheimer (D),
Hank Johnson (D),
Tom Kean (R),
Bill Keating (D),
Mike Kennedy (R),
Timothy Kennedy (D),
Young Kim (R),
Nick Langworthy (R),
John Larson (D),
George Latimer (D),
Mike Lawler (R),
Stephen Lynch (D),
Ryan Mackenzie (R),
Nicole Malliotakis (R),
Celeste Maloy (R),
Doris Matsui (D),
Sarah McBride (D),
April McClain-Delaney (D),
LaMonica McIver (D),
Joe Neguse (D),
Eleanor Holmes Norton (D),
Burgess Owens (R),
Jimmy Panetta (D),
Chellie Pingree (D),
Josh Riley (D),
Deborah Ross (D),
David Rouzer (R),
Raul Ruiz (D),
John Rutherford (R),
Mikie Sherrill (D),
Adrian Smith (R),
Chris Smith (R),
Paul Tonko (D),
David Valadao (R),
Jeff Van Drew (R),
Eugene Vindman (D),
Bonnie Watson Coleman (D),
Randy Weber (R),
Last Action
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. (on 03/25/2025)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/119th-congress/house-bill/2343/all-info |
| BillText | https://www.congress.gov/119/bills/hr2343/BILLS-119hr2343ih.pdf |
Loading...